PubMed

Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.

Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B; LIFE Study Investigators.

Ann Intern Med. 2007 Sep 4;147(5):311-9.PMID: 17785486 [PubMed - indexed for MEDLINE]Related articlesFree article

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.

Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B.

JAMA. 2006 Sep 13;296(10):1242-8.PMID: 16968848 [PubMed - indexed for MEDLINE]Related articlesFree article

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B; LIFE Study Investigators.

JAMA. 2004 Nov 17;292(19):2343-9.PMID: 15547161 [PubMed - indexed for MEDLINE]Related articlesFree article

In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.

Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Lindholm LH, Dahlöf B; LIFE Study Investigators.

Hypertension. 2007 Nov;50(5):984-90. Epub 2007 Sep 24.PMID: 17893425 [PubMed - indexed for MEDLINE]Related articlesFree article

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.

Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.

Circulation. 2007 Aug 14;116(7):700-5. Epub 2007 Jul 30.PMID: 17664372 [PubMed - indexed for MEDLINE]Related articlesFree article

Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.

Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B; LIFE Study Investigators.

Circulation. 2006 Jan 3;113(1):67-73. Epub 2005 Dec 19.PMID: 16365195 [PubMed - indexed for MEDLINE]Related articlesFree article

Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.

Okin PM.

J Electrocardiol. 2009 Nov-Dec;42(6):584-8. Epub 2009 Jul 24.PMID: 19631946 [PubMed - in process]Related articles

Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.

Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.

Circ Arrhythm Electrophysiol. 2008 Dec;1(5):337-43. Epub 2008 Dec 2.PMID: 19808428 [PubMed - indexed for MEDLINE]Related articles

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B; Losartan Intervention for Endpoint reduction in hypertension Study Investigations.

Circulation. 2003 Aug 12;108(6):684-90. Epub 2003 Jul 28.PMID: 12885747 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.

Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B; LIFE Study Investigators.

Circulation. 2006 Mar 28;113(12):1588-96. Epub 2006 Mar 13.PMID: 16534012 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic significance of left ventricular mass change during treatment of hypertension.

Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B.

JAMA. 2004 Nov 17;292(19):2350-6.PMID: 15547162 [PubMed - indexed for MEDLINE]Related articlesFree article

Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.

Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.

Hypertension. 2000 Nov;36(5):766-73.PMID: 11082141 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.

Oikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM; LIFE Study Investigators.

Am Heart J. 2003 May;145(5):919-25.PMID: 12766755 [PubMed - indexed for MEDLINE]Related articles

Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.

Devereux RB, Palmieri V, Liu JE, Wachtell K, Bella JN, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Dahlöf B.

J Hypertens. 2002 Jul;20(7):1445-50.PMID: 12131543 [PubMed - indexed for MEDLINE]Related articles

Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.

Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, Dahlöf B, Devereux RB.

Hypertension. 2007 Feb;49(2):311-6. Epub 2006 Dec 18.PMID: 17178978 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB; LIFE Study Investigators.

Circulation. 2009 Apr 14;119(14):1883-91. Epub 2009 Mar 30.PMID: 19332468 [PubMed - indexed for MEDLINE]Related articles

Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.

Okin PM, Wachtell K, Devereux RB, Nieminen MS, Oikarinen L, Viitasalo M, Toivonen L, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Kjeldsen SE, Julius S, Dahlöf B; LIFE Study Investigators.

Am J Hypertens. 2008 Mar;21(3):273-9. Epub 2008 Jan 24.PMID: 18219298 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB.

J Am Coll Cardiol. 2005 Mar 1;45(5):712-9.PMID: 15734615 [PubMed - indexed for MEDLINE]Related articles

Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.

Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlöf B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM; LIFE Study Investigators.

J Hypertens. 2006 Apr;24(4):775-81.PMID: 16531808 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.

J Am Coll Cardiol. 2005 Mar 1;45(5):705-11.PMID: 15734614 [PubMed - indexed for MEDLINE]Related articles